Article
Article name Role of Acidosis in the Mechanisms of Formation of Multiple Organ Failure (MOF)
Authors Alfonsova Y.V.Candidate of Science (Medicine) elena-alfonsova@yandex.ru
Zabrodina L.A.postgraduate, Department of Medical and Biological bases of Physical Education and Sports Alfonsova@zabspu.ru
Bibliographic description
Section
DOI
UDK 616-092.19
Article type
Annotation The authors carry out the analysis of review of literature about the influence of lactate acidosis in the development of multiple organ failure at the patients being in critical state. Hyperlactatemia is one of the most wide-spread metabolic disturbances at patients in critical state. It accompanies the most difficult phase of systemic inflammatory response, i.e. multiple organ failure (MOF). During emergency state at patients the precursors of multiple organ failure (MOF) are often aggravating metabolic disturbances in organs, systems and tissues with the development of syndrome hypermetabolic hypoxemia. In these conditions mitochondria becomes more sensitive to acidosis, incompletely oxidized metabolic products launch the mechanism of “mitochondrial dysfunction” and close the vicious circle of metabolic disturbances by increasing hypoxemia. Such changes occur in the myocardial metabolism and they lead it to structural changes. Myocardial infarction (MI) is the corollary of them. Because of it, the working of theoretical principles of the development of multiple organ failure (MOF) and its pathogenetically proved prophylaxis and treatment are at the centre of attention of scientists.
Key words lactate acidosis, mitochondrial dysfunction, multiple organ failure (MOF), critical states, hypoxemia, systemic inflammatory response (SIRS).
Article information
References 1. Al’fonsov V. V., Al’fonsova E. V. Gemostaz, morfologicheskii ekvivalent DVS-sindroma i narushenie strukturnoi organizatsii serdtsa pri metabolicheskom atsidoze // Vestn. Irkutsk. RO AN VSh Rossii. 2001. № 1. S. 156–164. 2. Barkagan Z. S., Momont A. P. Osnovy diagnostiki narushenii gemostaza. M.: N’yudiamed- AO, 1999. 224 s. 3. Berezov T. T., Korovin B. F. Biologicheskaya khimiya: uchebnik. 3-e izd., pererab. i dop. M.: Meditsina, 1998. 704 s. 4. Byshevskii A. Sh. i dr. Vliyanie vazhneishikh vitaminov-antioksidantov na nepreryvnoe vnutrisosudistoe svertyvanie i tole-rantnost’ k trombinu. M.: Med. kn., 2009. 112 s. 5. Vasyuk Yu. A. i dr. Vtorichnaya mitokhondrial’naya disfunktsiya pri ostrom koronarnom sindrome // Rats. farmakoter. 2007. № 1. S. 41–47. 6. Vitkovskii Yu. A., Kuznik B. I., Solpov A. V. Vliyanie interleikinov 1β i 8 na sekretsiyu T- i v-limfotsitami prokoagulyantov, antikoagulyantov i fibrinoliticheskikh agentov // Immunologiya. 2001. № 6. S. 24–27. 7. Vladimirov Yu. A. Svobodnye radikaly v biologicheskikh siste-makh // Sorosovskii obrazovatel›nyi zhurn. 2000. № 6(12). S. 13–19. 8. Gorodetskii V. K. Patofiziologiya uglevodnogo obmena // Klinicheskaya laboratornaya diagnostika. 2006. № 2. S. 25–32. 9. Dement›eva I. I. Monitoring kontsentratsii laktata i kislorodnogo statusa dlya diagnostiki i korrektsii gipoksii u bol›nykh v kriticheskom sostoyanii // Klinicheskaya laboratornaya diagnostika. 2003. № 3. S. 25–32. 10. Dolgikh V. T., Larin A. I., Pilipchuk I. A. Metabolicheskie narusheniya pri kriticheskikh sostoyaniyakh // Politravma. 2007. № 3. S. 73–77. 11. Dolgikh. V. T. Patofiziologiya obmena veshchestv. M.: Med. kn., 2002. 125 s. 12. Kudlai D. A., Efremov A. V. Osobennosti dinamiki soderzhaniya provospalitel›nykh tsitokinov interleikina-1β, interleikina-6 i interferona- γ v syvorotke krovi bol›nykh s sochetannoi i mnozhestvennoi travmoi, soprovozhdayushcheisya rabdomiolizom // Vestn. Ros. voen.-med. akademii. 2007. № 1. S. 49–52. 13. Kuznik B. I. Kletochnye i molekulyarnye mekhanizmy regulyatsii sistemy gemostaza v norme i patologii. Chita: Ekspress-izdatel›stvo, 2010. 827 s. 14. Lenindzher A. Biokhimiya. Molekulyarnye osnovy struktury i funktsii kletki. M.: Mir, 1999. 320 s. 15. Okorokov A. I. Lechenie boleznei vnutrennikh organov. Kn. 1. Lechenie boleznei serdtsa i sosudov. M.: Med. lit., 2002. T. 3. 80 s. 16. Rybintsev V. Yu., Pasechnik I. N., Bondarenko E. D. Otsenka ef-fektivnosti geparinoterapii u bol›nykh v kriticheskikh sostoyaniyakh // Vestn. intensivnoi terapii. 2006. № 5. S. 70–77. 17. Ryamova K. A., Rozenfel›d A. S. Osobennosti dykhaniya mitokhon-drii pri gipoksii i atsidoze // Vestn. YuUrGU. 2008. № 19. S. 31–35. 18. Sokolov V. A. i dr. Sindrom vzaimnogo otyagoshcheniya povrezhde-nii u postradavshikh s sochetannoi travmoi // Vestn. khirurgii. 2006. № 3. S. 3–9. 19. Sokolov V. A., Fedorova T. A. Profilaktika i lechenie sindroma poliorgannoi nedostatochnosti u rodil›nits s massivnoi krovopoterei // Vopr. ginekologii, akusherstva i perinatalogii. 2006. № 5(6). S. 41–48. 20. Timirbaev V. Kh., Vladimirova E. S., Valetova V. V. Printsipy intraoperatsionnoi terapii massivnoi krovopoteri v ekstrennoi khirurgii // Zdravookhranenie i med. tekhnika. 2005. № 10(24). S. 20–22. 21. Titov V. N., Lisitsyn D. M. Inye predstavleniya ob obrazovanii ketonovykh tel, kinetike β-okisleniya zhirnykh kislot i patogeneze ketoatsidoza // Klinicheskaya laboratornaya diagnostika. 2005. № 3. S. 3–9. 22. Khvatov V. B. i dr. Osobennosti i monitoring transfuzionnoi gemokorrektsii v neotlozhnoi khirurgii // Al›manakh klin. meditsiny. 2009. № 20. S. 16–20. 23. Chesnokova N. P., Ponukalina E. V., Bezenkova M. N. Molekulyarno-kletochnye mekhanizmy tsitotoksicheskogo deistviya gipoksii. Patogenez gipoksicheskogo nekrobioza // Sov. nauch. tekhnologii. 2006. № 7. S. 31–38. 24. Shteinle A. V. Patologicheskaya fiziologiya i sovremennye printsipy lecheniya tyazhelykh sochetannykh travm // Sib. med. zhurn. 2009. № 3. S. 119–127. 25. Shurkalin B. K., Faller A. P., Gorskii V. A. Khirurgicheskie aspekty lecheniya rasprostranennogo peritonita // Khirurgiya. 2007. № 2. S. 24–28. 26. Daniel De Backer. Lactic acidosis // Intensive Care Med. 2003. № 29. Р. 699–702. 27. Kette F., Weil M. H., Von Planta M. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation // Circulation. 1990. № 81. P. 1660–1666. 28. Ou H.C. et al. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells // Chem. Biol. Interact. 2006. № 161. Р. 1–13. 29. Shahruar S., Carlson R. W. Type A lactic acidosis in cardiogenic shock // Crit. Care Med. 2000. № 28(12). Р. 32–39.
Full articleRole of Acidosis in the Mechanisms of Formation of Multiple Organ Failure (MOF)